Castellum (CTM) Files Form 144 to Sell 500K Shares via First Georgetown

Rhea-AI Filing Summary

Castellum, Inc. (CTM) filed a Form 144 notifying the proposed sale of 500,000 shares of Common Stock through First Georgetown Securities Inc with an aggregate market value of $640,000 and an approximate sale date of 08/18/2025 on the NYSE. The filing lists total shares outstanding of 930,900,584. It discloses the acquisition history for the securities to be sold: purchases and conversions on 07/22/2019, 05/02/2020, and a merger-related acquisition on 06/10/2019, totaling recorded amounts of 168,215, 305,000, and 26,785 shares respectively. The filer also reported a sale on 05/19/2025 of 259,400 shares for gross proceeds of $278,673.20. The filer attests there is no undisclosed material adverse information.

Positive

• Full disclosure of proposed sale including broker, share count, aggregate market value, and sale date
• Acquisition history provided showing date and nature of how the securities were acquired
• Recent sale disclosed (05/19/2025) with amount and gross proceeds, enhancing transparency
• Filer attestation that no undisclosed material adverse information exists

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Routine insider disclosure of a proposed Rule 144 sale; appears procedurally complete.

The Form 144 provides required details: broker name, number of shares to be sold, aggregate market value, approximate sale date, outstanding shares, acquisition dates and nature, and a recent sale within the past three months. These elements align with Rule 144 disclosure requirements and the signature attestation is present. From a compliance perspective, the filing appears to meet procedural requirements for notification of an intended sale under Rule 144.

Securities Transaction Analyst

TL;DR: Transaction details show ongoing disposition of holdings, including a May 2025 sale and a new notice for August 2025.

The filing documents both prior disposition activity and a new proposed sale, specifying acquisition types (purchase, note conversion, merger) and payment methods (including warrant exercise). For trading and reporting oversight, notable items include the broker identification and the explicit aggregate market value, which support trade execution and public transparency. No forward-looking statements or financial performance data are included.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	First Georgetown Securities Inc Diagonal Rd ste 200 Alexandria VA 22314	500000	640000.00	930900584	08/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/22/2019	Purchase	Company			168215	07/22/2019	warrant exercise
Common Stock	05/02/2020	Conversion of Note	Company			305000	05/02/2020	Note Conversion
Common Stock	06/10/2019	Merger	Company			26785	06/10/2019	Merger Consolidation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jay Wright 9752 AVENEL FARM DR Patomic MD 20854	Common stock	05/19/2025	259400	278673.20

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being reported in the CTM Form 144 filing?

The filing reports a proposed sale of 500,000 shares of Common Stock with an aggregate market value of $640,000, to be sold approximately on 08/18/2025 on the NYSE.

Who is the broker listed for the proposed sale in the CTM Form 144?

The broker named is First Georgetown Securities Inc, located in Alexandria, VA.

Has the filer sold any CTM shares recently?

Yes. The filer sold 259,400 shares on 05/19/2025 for gross proceeds of $278,673.20.

What acquisition methods are disclosed for the shares to be sold?

Acquisitions include a purchase (07/22/2019, warrant exercise), a note conversion (05/02/2020), and a merger consolidation (06/10/2019).

Does the filer assert any undisclosed material information about Castellum, Inc.?

The filer signs an attestation representing they do not know of any material adverse information